Michael McCormack

In the matter of Part 6 of the Pharmacy Act 2007 

Mr Michael McCormack MPSI (Reg. No. 6261) 

Following the submission of a report of the Professional Conduct Committee (the “Committee”), the Council, at its meeting on 14 February 2019, decided to attach conditions to the registration of Mr Michael McCormack MPSI and to give public notice of those conditions under section 57 of the Pharmacy Act 2007. The conditions, as set out below, have expired. However, in accordance with the PSI’s Publications & Disclosure Policy 2022, public notice of the conditions which attached to the registration of a pharmacist or pharmacy following fitness to practise proceedings shall remain on the website for a period of 2 years following the expiry of those conditions.

Conditions formerly attached to Mr McCormack’s registration as a pharmacist are as follows: 

(i) That Mr McCormack shall enter into a mentoring programme for a period of eighteen months with a practising Superintendent Pharmacist (“the Mentor”), acceptable to the Registrar of the PSI (“the Registrar”). Mr McCormack shall meet with the Mentor on at least four occasions during the eighteen-month period. 

The Mentor shall provide advice and guidance to Mr McCormack in relation to the following areas of Mr McCormack’s practise which the Professional Conduct Committee found were deficient: 

(a) Compliance with the requirement for the sale and supply of medicinal products to be conducted by or under the personal supervision of a registered pharmacist; 

(b) Maintenance of controlled drug register; 

(c) Supply of controlled drugs; 

(d) Supply of medications on the High Tech scheme; 

(e) Maintenance of prescription register 

(f) Storage of medicinal products; an 

(g) Standard operating procedures. 

(i) Mr McCormack shall comply with the advice, guidance and recommendations of the Mentor. The Mentor shall issue a report to the Registrar twice during the eighteen month period; after a period of 9 months and at the conclusion of the 18 month period. 

(ii) Mr McCormack shall engage a pharmacist (“the Auditor”), acceptable to the Registrar of the PSI, to carry out an audit of his practise, wheresoever that may be carried out, each year for a period of three years from the commencement of these conditions. A report of each audit shall be provided by the Auditor to the Registrar following each audit. 

The Auditor shall audit and duly report on the following areas of Mr McCormack’s practise which the Professional Conduct Committee found were deficient: 

(a) Compliance with the requirement for the sale and supply of medicinal products to be conducted by or under the personal supervision of a registered pharmacist; 

(b) Maintenance of controlled drug register; 

(c) Supply of controlled drugs; 

(d) Supply of medications on the High Tech scheme; 

(e) Maintenance of prescription register; 

(f) Storage of medicinal products; and 

(g) Standard operating procedures.

(iii) Mr McCormack shall discharge all costs associated with the implementation of, and his compliance with, these conditions.

Date of Notice: 31 August 2023